A complication of the infusaid pump: Duodenal atony reversed by urecholine

Allan W. Silberman, Eliot Rosenkranz, Christopher Kosakowski, Arun Chervu, Roy I. Sugasawara, Kenneth P. Ramming

Research output: Contribution to journalArticle

Abstract

The totally implantable infusion pump (Infusaid pump) for treating metastatic disease to the liver is a new treatment that is gaining widespread acceptance. However, as might be expected for any new major surgical procedure, there are increasing reports of complications. We report a complication in which duodenal atony was caused by the infusion of the chemotherapeutic agent (FUDR) into the stomach and duodenum. The atony was totally reversed by the subcutaneous administration of Urecholine.

Original languageEnglish (US)
Pages (from-to)210-214
Number of pages5
JournalJournal of surgical oncology
Volume36
Issue number3
DOIs
StatePublished - Nov 1987
Externally publishedYes

Keywords

  • FUDR
  • Infusaid pump
  • liver
  • metastatic disease

ASJC Scopus subject areas

  • Surgery
  • Oncology

Fingerprint Dive into the research topics of 'A complication of the infusaid pump: Duodenal atony reversed by urecholine'. Together they form a unique fingerprint.

  • Cite this

    Silberman, A. W., Rosenkranz, E., Kosakowski, C., Chervu, A., Sugasawara, R. I., & Ramming, K. P. (1987). A complication of the infusaid pump: Duodenal atony reversed by urecholine. Journal of surgical oncology, 36(3), 210-214. https://doi.org/10.1002/jso.2930360312